EC5026

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

EC5026 具有通过稳定天然镇痛和抗炎介质来缓解疼痛的潜力。 EC5026 (BPN-19186) 是一种一流的小分子，可有效抑制可溶性环氧化物水解酶 (sEH)，这是一种参与膜脂肪酸代谢的关键调节酶。抑制 sEH 通过稳定天然镇痛和抗炎介质来治疗疼痛。

EC5026 has the potential to relieve pain by stabilizing natural analgesic and anti-inflammatory mediators.?EC5026 (BPN-19186) is a first-in-class, small molecule that potently inhibits soluble Epoxide Hydrolase (sEH), a key regulatory enzyme involved in the metabolism of membrane fatty acids.?Inhibition of sEH treats pain by stabilizing natural analgesic and anti-inflammatory mediators.?sEH inhibitors developed by EicOsis have already shown efficacy for treating pain with no apparent adverse or addictive effects in laboratory animals and relieving naturally occurring pain in dogs, cats and horses.

——

EC5026 (BPN-19186) has already shown efficacy for treating pain with no apparent adverse or addictive effects in laboratory animals and relieving naturally occurring pain in dogs, cats and horses.

BPN-19186

Others

Other Targets

sEH

——

——

1809885-32-2

405.39

C18H23F4N3O3

>98% (HPLC)

DMSO:250 mg/mL (616.69 mM)

O=C(NC1CCN(C([C@@H](C)CC)=O)CC1)NC2=CC=C(OC(F)(F)F)C(F)=C2

——

(-20℃)

With Ice Pack

≥ 2 years